MucoLife Therapeutics, an alumnus of the Health Wildcatters accelerator, develops patented, innovative mucus-dissolving therapies specifically targeting pulmonary mucus obstruction. In response to ...

CSA Medical, Inc., a medical device company focused on interventional pulmonary therapies, today announced the submission of ...

Researchers may have found a new target in chronic obstructive pulmonary disease (COPD) symptoms that could potentially save more lives. The study focused on mucus plugs, which clog airways in the ...

Airway-blocking mucus plugs were associated with a faster decrease in lung function in chronic obstructive pulmonary disease (COPD), a longitudinal study showed. Decrease in the forced expiratory ...

CHAPEL HILL, N.C. & MIAMI--(BUSINESS WIRE)--Renovion and the COPD Foundation have announced the creation of a new partnership to accelerate the development of a novel therapy for the treatment of ...

Please provide your email address to receive an email when new articles are posted on . Researchers found a link between mucus plugs in at least three lung segments and respiratory and cancer ...

A retrospective analysis of data of patients with chronic obstructive pulmonary disease (COPD) suggests that mucus plugs could contribute to patient mortality, offering a possible treatment target.

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, most often caused by cigarette smoking or long-term exposure to air pollutants. While there is ...

Chronic obstructive pulmonary disease, or COPD, is the fourth leading cause of death worldwide, responsible for 3.5 million deaths in 2021, according to the World Health Organization. It’s a common ...

In a longitudinal study, decrease in FEV 1 was greatest in those with mucus plugs that persisted over 5 years, followed by those who developed them during that period. Mucus plugs affect some 40% to ...